Story perspectives
Stem Cell Therapy Cuts Heart Failure Risk by 57%
10/30/2025
28 2
1 of 1
Story summary
- The BMJ published a study on stem cell therapy after a heart attack.
- The trial involved 396 participants in Iran, with 136 receiving stem cell infusions and 260 receiving standard care.
- Stem cell treatment yielded a 57% lower risk of heart failure and a 78% reduction in hospitalizations.
- The therapy did not affect overall mortality.
- Researchers say further studies are needed to confirm findings and understand mechanisms.
